Dr. Irina Primac | Nuclear Medicine | Best Researcher Award

Dr. Irina Primac, PhD, is an accomplished cancer biologist and radiopharmaceutical researcher, currently serving as Head of the Radiobiology Unit at the Belgian Nuclear Research Centre (SCK CEN). She leads a multidisciplinary team focusing on radiotheranostics and tumor microenvironment research, integrating molecular radiobiology with translational cancer therapy. With an H-index of 10, over 744 citations, and more than 25 peer-reviewed publications, Dr. Primac’s research demonstrates a strong impact on the fields of cancer radiotherapy, epigenetics, and radiopharmaceutical innovation. Her high-impact papers include contributions in Nature Reviews Clinical Oncology, Cell, and the Journal of Clinical Investigation, underscoring her international recognition. She has been awarded multiple EU-funded research grants such as Thera4Care and Accelerate.EU, leading preclinical work on FAPI-based radioligands for metastatic and triple-negative breast cancers. A recipient of several national and international research prizes and fellowships, Dr. Primac actively contributes to European cancer research initiatives and editorial boards. Her scientific vision centers on advancing precision oncology through next-generation theranostic platforms, bridging laboratory innovation with patient-centered cancer care.